Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Amyl Nitrite Inhalant
Active Ingredient: Amyl nitrite 98%w/v
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: James Alexander Corporation, Blairstown, New Jersey, United States of America
Note: This consent is valid for two years from 7 August 2007.
Product: Cerezyme
Active Ingredient: Imiglucerase-rch 212U
Dosage Form: Powder for infusion
New Zealand Sponsor: Healthcare Logistics
Manufacturer: Genzyme Corporation, Allston, Massachusetts, United States of America
Note: This consent is valid for two years from 29 July 2007.
Dated this 19th day of July 2007.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).